Medtronic Vascular is the lead sponsor of 9 current clinical trials in our Ireland, USA, China and UK registers. 6 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Cardiovascular Diseases.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
NCT07115953 · Hypertension, Vascular Diseases, Cardiovascular Diseases
|
Not applicable | Recruiting | 2025-09 | Ireland, UK |
|
SPYRAL GEMINI Pilot Study
NCT06907147 · ClinicalTrials.gov ↗ · Hypertension, Vascular Diseases, Cardiovascular Diseases
|
Not applicable | Recruiting | 2025-05 | Ireland, USA |
|
Spyral InSight Study
NCT07013929 · ClinicalTrials.gov ↗ · Hypertension, Vascular Diseases, Cardiovascular Diseases
|
Not applicable | Recruiting | 2025-06 | Ireland |
|
Prevail Global Study
NCT06535854 · ClinicalTrials.gov ↗ · Coronary Artery Disease
|
Not applicable | Recruiting | 2025-02 | USA |
|
Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation
NCT07174622 · ClinicalTrials.gov ↗ · Hypertension, Cardiovascular Diseases, Vascular Diseases
|
Observational | Recruiting | 2025-10 | USA |
|
Symplicity China Study
NCT07081243 · ClinicalTrials.gov ↗ · Resistant Hypertension
|
Observational | Recruiting | 2025-11 | China |
|
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
NCT05198674 · ClinicalTrials.gov ↗ · Hypertension, Vascular Diseases, Cardiovascular Diseases
|
Not applicable | Active, closed | 2021-10 | Ireland, UK, USA |
|
RESOLUTE ONYX China RCT Study
NCT03466151 · ClinicalTrials.gov ↗ · Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases
|
Not applicable | Active, closed | 2018-04 | China |
|
RESOLUTE ONYX China Single Arm Study
NCT03471845 · ClinicalTrials.gov ↗ · Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases
|
Not applicable | Active, closed | 2018-03 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Ireland | 4 | 3 |
| Clinical trials in USA | 4 | 3 |
| Clinical trials in China | 3 | 1 |
| Clinical trials in UK | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| ReCor Medical | 4 |
| Concept Medical | 2 |
| Affiliated Hospital of Nantong University | 2 |
| Suzhou Municipal Hospital | 1 |
| Beijing Institute of Heart, Lung and Blood Vessel Diseases | 1 |
| Soochow University | 1 |
Sponsors with the most current trials registered for this condition.
Medtronic Vascular is the lead sponsor of 9 current trials on ClinicalTrials.gov in our Ireland, USA, China and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 6 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Yes. 4 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.